Every patient with cancer and cancer survivor should undergo screening for pain at each follow-up visit, and clinicians should individualize the recommendations for intervention as indicated by each patient’s self-reported pain, according to the first-ever clinical guidelines for managing pain in cancer survivors recently published by a panel expert convened by the American Society of Clinical Oncology (ASCO). Read More ›

FDA News - September 2016

FDA Approvals, News & Updates

Medications Used for the Treatment of Prostate Cancer

By Kristin A. Esposito, CPhT

Cancer Drug Coding

Are Oncology Practice Managers Still Having Fun?

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

First FDA-Approved Blood Test for Colorectal Cancer May Offer a Convenient Screening Alternative for Some Patients